Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pharmacist supply of sildenafil: pharmacists’ experiences and perceptions on training and tools for supply

Pharmacist supply of sildenafil: pharmacists’ experiences and perceptions on training and tools... Background In 2014, New Zealand reclassified sildenafil (for erectile dysfunction) to allow supply by specially trained pharmacists under strict criteria. Objective The study aimed to determine pharmacists’ experiences and perspectives on the training for, and supply of sildenafil under this model. Setting New Zealand community pharmacy. Method This qualitative study captured data with a semi-structured interview used with purposively-sampled participants. A maximum variation sample was used to select a wide range of pharmacists working in various pharmacies, including pharmacists who were trained to provide sildenafil and those not trained to supply sildenafil. Consenting pharmacists were interviewed, with interviews audio-recorded and transcribed. Analysis used a framework approach. Main outcome measures Topics explored included: satisfaction and experience of the training; suitability and usability of the screening tools; experiences of the supply process and why some pharmacists chose not to become trained. Results Thirty-five pharmacists were interviewed. Training was seen as uncomplicated and the screening tools provided confidence that key consultation areas were covered. Most consultations reportedly took 15–20 min, some up to 60 min. Pharmacists reported being comfortable with the consultations. Many men requesting supply fell outside of the parameters, resulting in medical referral. This new model of supply was seen as a positive for pharmacists and their patients. Unaccredited pharmacists reported a perceived lack of interest from men, or ability to provide the service as reasons for not seeking accreditation. Conclusion New Zealand’s model of pharmacist supply of sildenafil appears workable with some areas for improvement identified. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Clinical Pharmacy Springer Journals

Pharmacist supply of sildenafil: pharmacists’ experiences and perceptions on training and tools for supply

Download PDF
9 pages

Loading next page...
 
/lp/springer_journal/pharmacist-supply-of-sildenafil-pharmacists-experiences-and-WNSStp7738
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Internal Medicine; Pharmacy
ISSN
2210-7703
eISSN
2210-7711
DOI
10.1007/s11096-018-0622-z
pmid
29605946
Publisher site
See Article on Publisher Site

Abstract

Background In 2014, New Zealand reclassified sildenafil (for erectile dysfunction) to allow supply by specially trained pharmacists under strict criteria. Objective The study aimed to determine pharmacists’ experiences and perspectives on the training for, and supply of sildenafil under this model. Setting New Zealand community pharmacy. Method This qualitative study captured data with a semi-structured interview used with purposively-sampled participants. A maximum variation sample was used to select a wide range of pharmacists working in various pharmacies, including pharmacists who were trained to provide sildenafil and those not trained to supply sildenafil. Consenting pharmacists were interviewed, with interviews audio-recorded and transcribed. Analysis used a framework approach. Main outcome measures Topics explored included: satisfaction and experience of the training; suitability and usability of the screening tools; experiences of the supply process and why some pharmacists chose not to become trained. Results Thirty-five pharmacists were interviewed. Training was seen as uncomplicated and the screening tools provided confidence that key consultation areas were covered. Most consultations reportedly took 15–20 min, some up to 60 min. Pharmacists reported being comfortable with the consultations. Many men requesting supply fell outside of the parameters, resulting in medical referral. This new model of supply was seen as a positive for pharmacists and their patients. Unaccredited pharmacists reported a perceived lack of interest from men, or ability to provide the service as reasons for not seeking accreditation. Conclusion New Zealand’s model of pharmacist supply of sildenafil appears workable with some areas for improvement identified.

Journal

International Journal of Clinical Pharmacy – Springer Journals

Published: Mar 31, 2018

References

  • Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison
    Gauld, NJ; Kelly, FS; Kurosawa, N; Bryant, LJM; Emmerton, LM; Buetow, SA
  • Changing the status of drugs from prescription to over-the-counter availability
    Brass, EP
  • Over the counter drugs: the future for self medication
    Bradley, C; Blenkinsopp, A
  • Why the resurgence of OTC reclassifications in the UK is a good thing
    Gauld, N
  • UK community pharmacists experiences on over-the-counter tamsulosin
    Ahmed, S; Rutter, PM
  • Simvastatin for self-medication in the UK
    Mann, S
  • Over-the-counter prescribing and pharmacists’ adoption of new medicines: diffusion of innovations
    Paudyal, V; Hansford, D; Cunningham, S; Stewart, D
  • Over-the-counter triptans–making the switch
  • Impotence
  • Should sildenafil be available over the counter?
    Rubin, N; Wylie, K
  • Diagnosis and treatment of erectile dysfunction
    Tsertsvadze, A; Yazdi, F; Fink, HA; MacDonald, R; Wilt, TJ; Soares-Weiser, K
  • Improvement in emotional well-being and relationships of users of sildenafil
    Paige, NM; Hays, RD; Litwin, MS; Rajfer, J; Shapiro, MF
  • Definitions/epidemiology/risk factors for sexual dysfunction
    Lewis, RW; Fugl-Meyer, KS; Corona, G; Hayes, RD; Laumann, EO; Moreira, ED
  • Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association
    Levine, GN; Steinke, EE; Bakaeen, FG; Bozkurt, B; Cheitlin, MD
  • Erectile dysfunction
    Shamloul, R; Ghanem, H
  • Health-related characteristics and unmet needs of men with erectile dysfunction: a survey in five European Countries
    Jannini, EA; Sternbach, N; Limoncin, E; Ciocca, G; Gravina, GL; Tripodi, F
  • The EPIFARM study: an observational study in 574 community pharmacies in Spain characterizing patient profiles of men asking for erectile dysfunction medication
    Morales, AM; Ibanez, J; Machuca, M; Pol-Yanguas, E; Schnetzler, G; Renedo, VP
  • The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers
    Shaeer, O
  • Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
    Jackson, G; Arver, S; Banks, I; Stecher, VJ
  • Sexual behavior, sexual dysfunction and related help seeking patterns in middle-aged and elderly Europeans: the global study of sexual attitudes and behaviors
    Nicolosi, A; Buvat, J; Glasser, DB; Hartmann, U; Laumann, E; Gingell, C
  • Male erectile dysfunction: its prevalence in Western Australia and associated sociodemographic factors
    Chew, KK; Stuckey, B; Bremner, A; Earle, C; Jamrozik, K
  • Screening and managing erectile dysfunction in diabetic patients (review)
    Colson, MH; Roussey, G
  • An overview of current pharmacy impact on immunisation a global report 2016
  • Pharmacist-prescribed birth control in Oregon and other states
    Yang, YT; Kozhimannil, KB; Snowdon, JM
  • Pharmacist prescribing of hormonal contraceptives: results of the direct access study
    Gardner, JS; Miller, L; Downing, DF; Le, S; Blough, DK; Shotorbani, S
  • Evaluation of a community pharmacy delivered oral contraception service
    Parsons, J; Adams, C; Aziz, N; Holmes, J; Jawad, R; Whittlesea, C
  • Pharmacist-only trimethoprim: pharmacist satisfaction on their training and the impact on their practice
    Braund, R; Henderson, E; McNab, E; Sarten, R; Wallace, E; Gauld, N
  • Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim
    Gauld, NJ; Zeng, ISL; Ikram, RB; Thomas, MG; Buetow, SA
  • Community pharmacists’ adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making
    Paudyal, V; Hansford, D; Cunningham, S; Stewart, D
  • Pharmacists’ perceived integration into practice of over-the-counter simvastatin five years post reclassification
    Paudyal, V; Hansford, D; Cunningham, S; Stewart, D
  • Qualitative research and evaluation methods
    Patton, MQ
  • Qualitative research in health care. Analysing qualitative data
    Pope, C; Ziebland, S; Mays, N
  • Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand
    Gauld, N; Kelly, F; Shaw, J
  • Five years of non-prescription oseltamivir: effects on resistance, immunization and stock-piling
    Gauld, NJ; Jennings, LC; Frampton, C; Huang, QS
  • Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study
    Hattingh, HL; Sim, TF; Parsons, R; Czarniak, P; Vickery, A; Ayadurai, S
  • Availability of emergency contraception after its deregulation from prescription-only status: a survey of Ontario pharmacies
    Dunn, S; Brown, TER; Alldred, J
  • A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment
    Symonds, T; Dean, JD; Carr, A; Carlsson, M; Marfatia, A; Schnetzler, G
  • The use of a written assessment checklist for the provision of emergency contraception via community pharmacies: a simulated patient study
    Schneider, CR; Gudka, S; Fleischer, L; Clifford, RM
  • Pharmacists as immunizers: a survey of community pharmacists’ willingness to administer adult immunizations
    Edwards, N; Gorman Corsten, E; Kiberd, M; Bowles, S; Isenor, J; Slayter, K